Monitor how the company deploys the $134.6 million in new capital, particularly toward advancing its clinical programs for tibulizumab, crebankitug, and torudokimab. The cash position of $109.4 million pre-offering suggests runway extension, but watch for any changes in cash burn rate or strategic initiatives.
Price Chart
Executive Summary
Zura Bio Ltd (ZURA) raised approximately $134.6 million through a public offering of 18.2 million shares and pre-funded warrants for 1.8 million shares, priced at $6.25 per share. The company also disclosed a preliminary cash balance of $109.4 million as of December 31, 2025. The offering was upsized with the underwriters exercising their full 3 million share option.
Key Facts
- Zura Bio raised approximately $134.6 million in net proceeds from a public offering
- Offering consisted of 18.2 million shares at $6.25 per share and pre-funded warrants for 1.8 million shares
- Underwriters exercised their full option to purchase an additional 3 million shares
- Company reported preliminary cash balance of $109.4 million as of December 31, 2025
- Total outstanding shares will be 94,875,460 after the offering, assuming no warrant exercise
Financial Impact
Raised $134.6 million in net proceeds through equity offering, increasing share count by approximately 21.2 million (18.2 million shares + 3 million option shares)
Risk Factors
- Equity dilution from issuing approximately 21.2 million new shares
- Pre-funded warrants could lead to additional dilution if exercised
- Biotech clinical development risk for pipeline candidates
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 9 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-019827 |
| Document: tm267297d1_ex4-1.htm | 0001104659-26-019827 |
| Document: tm267297d1_ex5-1.htm | 0001104659-26-019827 |
| Document: tm267297d1_8k.htm | 0001104659-26-019827 |
| Document: tm267297d1_ex99-2.htm | 0001104659-26-019827 |
| Document: tm267297d1_ex99-1.htm | 0001104659-26-019827 |
| Document: 0001104659-26-019827-index-headers.html | 0001104659-26-019827 |
| Document: 0001104659-26-019827-index.html | 0001104659-26-019827 |
| Document: 0001104659-26-019827.txt | 0001104659-26-019827 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 17, 2026 10w ago | 8-K | $5.68 $4.93 | ▼ −13.20% | ▼ −11.23% | $3.36 (−40.85%) |
Aug 11, 2026 10w ago | 8-K | $5.56 $5.71 | ▲ +2.70% | ▲ +3.76% | $3.36 (−39.57%) |
Jul 1, 2026 16w ago | 8-K | $5.01 $5.31 | ▲ +6.09% | ▲ +8.28% | $3.36 (−32.87%) |
Jun 18, 2026 18w ago | 8-K | $4.23 $5.45 | ▲ +28.84% | ▲ +28.99% | $3.36 (−20.57%) |
May 7, 2026 24w ago | 8-K | $4.54 $3.86 | ▼ −14.98% | ▼ −18.11% | $3.36 (−25.99%) |
Mar 5, 2026 33w ago | 8-K | $6.76 $6.03 | ▼ −10.80% | ▼ −7.01% | $3.36 (−50.30%) |
Feb 26, 2026 34w ago | 8-K | $6.77 $6.04 | ▼ −10.78% | ▼ −4.38% | $3.36 (−50.37%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers